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Fibrillin-based human diseases such as Marfan syndrome and congenital contractural arachnodactyly implicate fibrillins in the function and
homeostasis of multiple adult tissues. Fibrillins are also expressed in embryos, but no early developmental role has been described for these
proteins. We use three independent methods to reveal a role for Xenopus fibrillin (XF) at gastrulation. First, expressing truncated forms of XF in
the embryo leads to failure of gastrulation concomitant with a dominant-negative effect on native fibrillin fibril assembly. Expressing truncated XF
also inhibits normal progression of the patterned, polarized cell motility that drives convergence and extension at gastrulation and perturbs directed
extension in cultured explants of dorsal mesoderm. Second, injection of a synthetic peptide encoding a cell-binding domain of XF into midgastrula
embryos causes acute failure of gastrulation associated with defective fibrillin fibril assembly. These injections also reveal a critical role for this
peptide in the fibril assembly process. Third, morpholino-mediated knockdown of translation of XF in the embryo also perturbs normal
gastrulation and directed extension. Together, these data show that native Xenopus fibrillin is essential for the process of directed convergent
extension in presumptive notochord at gastrulation.
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Vertebrate gastrulation is a combination of two intertwined
processes organized by Spemann's Organizer: morphogenetic
tissue movements driven by patterned cell motility that remodel
the embryo and the concomitant induction of specific cell fates,
and these spatially and temporally regulated cellular behaviors
are integrated over the entire presumptive notochordal/somitic
region, or dorsal involuting marginal zone (DIMZ), to drive
directed extension of this tissue along the anterior–posterior
axis and ultimately the generation of a mature notochord
flanked by segmented somites (Shih and Keller, 1992a,b; Keller
et al., 2000). The DIMZ is the “mechanical organizer” because
these deformations drive gastrulation in the whole embryo, and
cultured explants of DIMZ tissue (Keller explants) can
autonomously undergo morphological extension to generate
measurable force while anisotropically stiffening in the
direction of extension (Moore et al., 1995). Regulation of⁎ Corresponding author. Fax: +1 434 982 5626.
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doi:10.1016/j.ydbio.2006.09.005cellular motility in the DIMZ is critical for this morphogenesis
to occur; however, the locally acting molecular mechanisms that
modulate these behaviors to generate anisotropic tissue level
forces remain poorly defined (Shih and Keller, 1992b; Keller et
al., 2000).
Blastopore closure, most of involution at gastrulation, and
elongation of the embryo during normal gastrulation are
brought about by the posterior progression of expression of
specific cell behaviors collectively called mediolateral interca-
lation behavior (MIB) (Keller et al., 2000). DIMZ cells of the
early gastrula are isodiametric and exhibit randomly directed
protrusive activity but change their behavior during notochordal
morphogenesis. These cells adopt both an elongated shape
perpendicular to the axis of extension and exhibit mediolaterally
oriented bipolar protrusive activity (Shih and Keller, 1992a).
Expression of MIB is induced in presumptive notochordal cells
in an anterior-to-posterior and lateral-to-medial progression
driving cell intercalation and leading to convergence (narrow-
ing) and extension (lengthening) of notochord (convergent
extension or CE) (Shih and Keller, 1992b). During this time,
morphologically distinct structures composed of extracellular
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notochordal–somitic boundaries. These boundaries elongate
from anterior-to-posterior concomitant with notochordal devel-
opment and are essential for the “boundary capture”mechanism
of cell intercalation. An intercalating cell remains bipolar until it
contacts the boundary, at which time it locally ceases the
invasive intercalating type of protrusive activity at the
boundary-contacting end. Instead, it spreads in the plane of
the boundary and is stabilized or “captured” there, transiting to a
monopolar protrusive mode while at the same time elongating
the boundary (Shih and Keller, 1992b).
The first ECM component of the developing notochord–
somite boundary is Xenopus fibrillin (XF) (Skoglund et al.,
2006). Chick, mouse and human fibrillins are also found around
notochords (Gallagher et al., 1993; Wunsch et al., 1994; Zhang
et al., 1995; Rongish et al., 1998; Quondamatteo et al., 2002;
Czirok et al., 2004). Human fibrillins-1, -2 and -3 (Fbns1–3)
comprise a family of ECM glycoproteins that form filamentous
microfibrils that both supply biomechanical support in the body
and regulate signaling events. These proteins interact with cells
through both integrin and proteoglycan receptors as well as
ligands that include other ECM molecules and growth factors
(reviewed in Robinson and Godfrey, 2000). Mutations in Fbn 1
and 2 are responsible for the human diseases Marfan syndrome
(MFS) and congenital contractural arachnodactyly (CCA) and
MFS patients have variable life expectancy that correlates with
the severity of the allele inherited; some alleles exhibit a mild
phenotype with near-normal lifespan whereas others are more
severe, ranging to neonatal mortality (Dietz et al., 1994).
Here we examine the function of XF in the frog embryo by
employing three distinct interdictions of fibrillin fibril assembly,
all of which block normal progression of gastrulation in a
manner consistent with a defect in axial morphogenesis. These
data strongly implicate native XF fibrils at the notochord–
somite boundary in the normal process of convergent extension
of dorsal mesoderm during amphibian gastrulation and
additionally reveal a role for a conserved cell-binding domain
in XF in fibril assembly.
Results
Expression of a truncation mutant of Xenopus fibrillin (XF)
blocks gastrulation when expressed on the dorsal but not
ventral sides of the gastrula
Targeted injection of synthetic mRNA encoding two amino-
terminal truncated forms of XF, deletion-XF (delXF) and
twice-deleted XF (TdXF), was performed into either the
presumptive dorsal or ventral marginal zone of developing
Xenopus embryos (Fig. 1A). These experiments were moti-
vated by the observation that truncation alleles of human Fbn1
exert dominant-negative effects on fibrillin deposition into
matrix (see Schrijver et al., 2002). When expressed on the
dorsal side of the gastrula, where native XF is expressed
(Skoglund et al., 2006), normal progression of gastrulation is
blocked (Figs. 1B–G). In injected embryos the blastopore fails
to close (Figs. 1C–G), leading to failure of normal internal-ization of mesoderm and lack of archenteron elongation. This
failure is apparent first at late midgastulae stage (St. 11), when
dorsally injected embryos are retarded in closing their
blastopores with respect to control injected animals (Figs.
1G, H). Failure of morphogenesis in injected animals is not
due to a change in dorsal mesodermal cell fate because
notochord is still specified in injected animals (Fig. 1F).
Notochordal tissue is found in a ring around the open
blastopore and appears similar to classic “ring embryos”
generated by mechanically disrupting dorsal, axial tissue
(Schectman, 1942). In contrast, expression of deltaXF or
TdXF on the ventral side of the blastopore leads to background
levels of gastrulation defects, similar to expression of bovine
pre-prolactin on the dorsal or ventral side (Fig. 1B).
Gastrulation blocking activity localizes to carboxy-terminal
unique sequences
To address the molecular mechanism by which expressing
amino-terminal deleted forms of XF on the dorsal side of the
embryo perturbs gastrulation, we constructed two carboxy-
terminal truncations of TdXF (Fig. 1A). One of these, TdXF-
Protease (TdXF-P), is truncated at a putative furin protease
processing site where fibrillins are normally cleaved by
proteases during maturation (arrow in Fig. 1A). This truncation
acts like the parent construct (TdXF) and blocks normal
progression of gastrulation (Fig. 1B). In contrast, further
deletion of carboxy-terminal unique sequences produces
TdXF-Repeats (TdXF-R), which does not exhibit appreciable
gastrulation blocking activity and thus implicates the unique
sequences deleted from this protein in the molecular mechanism
that perturbs gastrulation (Fig. 1B).
Explants of DIMZ-expressing deltaXF extend abnormally
Because the phenotype of deltaXF/TdXF-injected embryos
and the localization of XF expression in the dorsal mesoderm
are both consistent with involvement of XF in DIMZ
convergent extension, we examined the effect of expressing
deltaXF in DIMZ explants (Keller explants) that converge and
extend autonomously. Keller sandwiches made from pairs of
dorsal marginal zones of injected embryos do not extend
properly. Notochords of approximately normal length and
volume form in explants derived from injected animals, but
these notochords are twisted and curled, and the severity of this
phenotype depends on the dose of deltaXF RNA injected (Figs.
2A–D). These results suggest that deltaXF injections perturb
the biomechanical mechanisms normally responsible for
directed extension of this tissue.
To further explore this effect, we examined open face
explants (derived from single embryos) unilaterally expressing
deltaXF. These explants were assayed for bending, either
towards or away from the injected side as determined by co-
expression of green fluorescent protein (GFP). Sixty-nine
percent (11 of 16) of deltaXF-injected explants bent towards
the injected side (Fig. 2E/F), and none bent away, suggesting
that extension is retarded in deltaXF-expressing regions. In
Fig. 1. deltaXF/TdXF expression perturbs gastrulation. (A) Schematic outline of the domain structure of the prototypical fibrillin and the injection constructs: deletion
XF (deltaXF), twice-deleted XF(TdXF) (similar to deltaXF but with a partial EGF repeat removed) and two carboxy-terminal deletions of TdXF, TdXF-Protease
(TdXF-P) and TdXF-Repeats (TdXF-R). Shown are calcium binding EGF-like repeats (gray ovals), EGF-like repeats (black ovals), 8-cysteine repeats (black
rectangles), hybrid repeats between EGF-like and 8-cysteine repeats (gray rectangles) unique sequences (lines and gray box), N-cad signal sequences (black oval and
pentagon—representing two distinct fusion sites between signal sequence and XF sequence) and furin processing site (arrow). (B) Percent of embryos exhibiting open
blastopores is plotted with SEM for presumptive dorsal vs. ventral mesoderm injection of deltaXF (D, n=56; V, n=49), TdXF (D, n=77; V, n=80), TdXF-P (D,
n=71; V, n=71), TdXF-R (D, n=75; V, n=59), pre-prolactin (PPL) (D, n=47; V, n=44) or uninjected embryos (n=195). (C) DeltaXF dorsally injected late
gastrula embryos exhibiting failure of blastopore closure and partial exogastrulation. Scale bars are 0.5 mm in panels C–H. (D) The same embryos as in panel C, but
visualizing co-injected GFP to reveal the dorsal targeting of these injections. (E) Dorsal deltaXF-injected St 22 embryo exhibiting open blastopore. (F) deltaXF-
injected embryo stained for a notochord marker (Tor70), which reveals notochord (N) ringing the yolk plug. (G and H) Frames from movies of developing embryos
injected with (G) TdXF or (H) PPL with elapsed time indicated. YP=yolk plug; n=notochord; NF=neural folds.
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the notochord and somitic mesoderm at the site of expression
(Fig. 2G/H arrowhead) suggesting a mechanical defect in
deltaXF-expressing tissue that could be due to altered matrix at
the notochord–somite boundary. Only 6% of the experimentalexplants (1/16) extended in a straight manner. In contrast to the
results with deltaXF, 73% of explants (11/15) unilaterally
expressing control secreted proteins extended straight, neither
bending or bifurcating, which is average for unmanipulated
explants (unpublished observation REK).
Fig. 2. Morphology and XF fibrils in deltaXF-expressing explants. (A–D) Keller sandwiches made from embryos injected with increasing doses of deltaXF, allowed to
extend and stained for notochord (N). Scale bar in panel B is 0.2 mm. (A) Control sandwich from uninjected embryos (representative example shown, n=5), (B–D)
0.5 ng, 1 ng and 2 ng deltaXF RNA per dorsal blastomere, respectively (n=3, 3 and 5, respectively). (E–H) Explants stained for native XF immunoreactivity (E and
G), and both native fibrils (red) and GFP (green), indicating the region of delXF expression, with yellow being the combined signal (F and H). Arrowhead in panel G
indicates bifurcation of explant, and bracket indicates region shown in panel H. Scale bars are 0.1 mm in panels E–J. (I) XF fibrils around notochord of an uninjected
open face explant and (J) XF fibrils in notochord region of explant globally expressing deltaXF.
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in wild-type fibrillin localization to the boundary
To determine whether expression of deltaXF has a dominant
effect on native XF localization or appearance, we examined
native XF in open face explants mosaically expressing deltaXF.
XF protein is normally concentrated at the notochord–somite
boundary, and the JB3 antibody used to visualize XF does not
detect the injection construct. This localization is clearly
disrupted in regions co-expressing deltaXF and GFP, as
reflected by a reduction of native fibrillin immunoreactivity at
the boundary in expressing regions, whereas neighboring
regions exhibit normal levels, localization and appearance of
XF (Figs. 2E/F and G/H). In explants expressing deltaXF
widely, native XF immunoreactivity is discontinuous and
disorganized and often lacks orientation with respect to any
embryonic axis, whereas in uninjected explants XF is
continuous and aligned in two oriented stripes corresponding
to the notochord–somitic boundaries (Figs. 2I, J).
Cells in the DIMZ expressing deltaXF behave abnormally
during gastrulation
The dominant effect of deltaXF on convergence and
extension could be due to an effect on the expression of MIB
exhibited by the cells of the DIMZ responsible for convergentFig. 3. Effect of deltaXF expression and CB1 peptide on cell behavior. (A and B) G
deltaXF expression perturbs notochordal cell behaviors. (A) Embryos injected with
explants, and two small groups of expressing cells, one from each type of injecte
midgastrulation. After healing, the DIMZ of this host embryo was explanted into cultu
extension. (B) A single frame from a movie showing morphology of GFP labeled,
experimentally injected (deltaXF+GFP; left of arrows) cells in an extending explant
cell, and most control cells have length-to-width ratios greater than 2, in contras
experimentally injected graft has maintained its cohesion during extension of the h
through the process of intercalation to generate intermixed labeled and unlabeled cell
cells can participate in morphogenesis. (C) CB-1 peptide does not affect notochordal c
explant undergoing morphogenesis to which CB-1 peptide is added at 50 μg/ml at fram
affected by acute application of the CB-1 peptide.extension. To address this issue, we used low-light time-lapse
fluorescent video microscopy to follow individual, transplanted
cells co-expressing deltaXF and GFP, or a control secreted
protein (prolactin) and GFP, during extension of an open-faced
explant in which the intercalating deep cells can be seen (Fig.
3A). In four such experiments, consistent behavioral differences
were observed between these two cell populations. DeltaXF/
GFP-expressing cells remained rounded and did not appreciably
participate in MIB.When assayed at the conclusion of extension
of the explant, only 3% of experimentally injected cells exhibit
the elongated morphology normally adopted by cells that are
expressing MIB (Fig. 3B; left side), compared to 53% of the
pre-prolactin/GFP injected, transplanted cells in the same
explants (Fig. 3B; right side). Consistent with a failure of
MIB in deltaXF-expressing cells, this population also showed
reduced extension as shown by a reduction in the extension ratio
(the anterior–posterior extent of the cell population at the
conclusion of the experiment divided by the starting extent).
Over three experiments, control injected cell populations
exhibited an extension ratio of 1.69±0.27 (SEM), typical of
open-faced explants at this stage (Shih and Keller, 1992a),
whereas experimentally injected cell populations exhibited a
ratio of 1.05±0.27. In addition, deltaXF-expressing patches of
cells do not intermingle with unlabeled host cells (Fig. 3B; left
side), whereas control patches do intercalate with host tissue to
generate mosaically labeled regions (Fig. 3B; right side).enetic mosaic transplantation analysis of deltaXF-expressing cells reveals that
either GFP and deltaXF or GFP and pre-prolactin were used to make DIMZ
d embryo, were transplanted above the dorsal lip of a single host embryo at
re and the labeled control and experimentally injected cells were observed during
transplanted control cells (injected with pre-prolactin+GFP; right of arrows) or
. Cells that exhibit an elongate morphology fit the profile of an MIB-expressing
t to deltaXF-expressing cells in the same explant. In addition, note that the
ost explant, in contrast to the control injected graft which has been broken up
s. This serves as a positive control for this experiment, indicating that the grafted
ell behavior. Time-lapse frames visualizing notochordal cell behavior in an axial
e t=0. In contrast to deltaXF expression above, notochordal cell behavior is not
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of motility because both experimental and control injected head
mesodermal cells exhibit characteristic migratory behaviors
over the surface of the explant after transplantation (data not
shown). Neither is this difference in behavior attributable to
generalized cell sickness or to a nonspecific response in axial
mesodermal cells to expression of deltaXF because deltaXF-
expressing cells obtained from regions adjacent to those
transplanted adhere to and actively extend and retract
lamellipodia when cultured on a fibronectin-coated plastic
substrate (data not shown).
The cell binding region peptide (CB-1) inhibits gastrulation
Because the carboxy-terminal unique sequences of XF are
required for the gastrulation arrest activity of TdXF (Fig. 1B),
we evaluated the possible role of a putative heparin/cell binding
protein motif (that we term cell binding 1 or CB-1) present in
this region. CB-1 is similar in sequence to motifs in human
fibrillins that are able to mediate cell attachment (Fig. 5B) (Ritty
et al., 2003), which overlap the multibasic site at which pro-
fibrillins are matured by furin-class proteases. Injecting a
synthetic peptide corresponding to the Xenopus CB-1 region
into the blastocoel of developing gastrula stage embryos leads
to a dramatic phenotype in which the normal progression of
gastrulation is perturbed, similar to that seen in dorsally injected
deltaXF embryos (Fig. 5A). CB-1-injected embryos fail to close
their blastopores, to normally internalize axial mesoderm and to
elongate their archenteron. At stage 25, injected animals exhibit
well-formed heads but almost completely lack trunks, leading to
short, wide animals with open blastopores (Fig. 4A). This
phenotype is not seen in parallel injections of a control peptide
(Fig. 4B). Time-lapse video recordings of injected animals
reveal a dramatic failure of mesodermal involution when they
are injected during the second half of gastrulation when axial
morphogenesis is occurring (Fig. 4G). These movies reveal a
gross change in the patterning of cell movements at gastrulation
in injected embryos similar to that seen in embryos injected
dorsally with deltaXF or TdXF, with mesoderm failing to
internalize at the dorsal blastopore lip. When CB-1 peptide is
injected at blastula stages, several hours before axial morpho-
genesis begins, no phenotype is observed until mid-gastrulation
(data not shown).
CB-1 peptide blocks fibril assembly, which correlates with
phenotype
To determine whether native XF fibrils are perturbed by CB-1
peptide injection, we stained injected animals for XF protein.
Most injected embryos exhibit a severe phenotype, having a
roughly spherical shape and a large open blastopore, with
normal morphogenesis blocked from mid-gastrulation on.
These embryos exhibit drastically reduced XF staining as
compared to uninjected siblings (Fig. 4C). A few injected
embryos that fail to close their blastopores exhibit some axial
morphogenesis; they have elongated in the anterior–posterior
direction and exhibit smaller open blastopores, and thiscorrelates with increased XF staining along the developing
axis (Fig. 4D). A minority of embryos are able to close their
blastopores and exhibit both relatively normal development
through gastrulation, and relatively normal XF staining, but
often display pertubations in the normal pattern of XF
deposition such as somitic staining on only one side of the
embryo (Fig. 4E/F).
Characterizing the XF CB-1 functional domain
To define what sequences in the CB-1 peptide are required for
gastrulation arrest activity, we produced an eight amino-acid
carboxy-terminal deletion of this peptide (delCB-1). This
peptide exhibits no gastrulation arrest activity when injected
into the blastocoel of developing embryos (Fig. 5A). Five
peptides representing point mutations in this region of the CB-1
peptide were made and assayed for gastrulation arrest activity,
and none inhibited gastrulation when injected into the
blastocoele of developing embryos (Fig. 5A/B). This region
also overlaps the six amino acid predicted furin cleavage site that
is the site of carboxy-terminal processing of pro-fibrillin into
mature fibrillin. Importantly, each of these peptides represents an
already cleaved product and therefore define this cluster of basic
amino acid residues as bi-functional; required for the both for the
gastrulation arrest activity exhibited by the CB-1 peptide and
also important for directing proteolytic processing during
maturation of intact fibrillins. Injecting a peptide that includes
the 10 amino acids from XF past this protease site (CB1+10)
leads to gastrulation arrest activity at similar frequency to CB-1
when injected on an equimolar basis, indicating that an intact
protease site does not affect the gastrulation arrest activity of
these peptides (Fig. 5A). A mutant version of this peptide
CB1+10 M is analogous to the mutation in the CB-1 M
mutant peptide, and also fails to exhibit gastrulation arrest
suggesting that the mechanism underlying gastrulation arrest
activity is the same for both the CB-1 and the CB1+10
peptides. In addition, because the mutation in the CB1+10 M
peptide is expected to inhibit processing at the protease site
we find no evidence for cell binding activity regulation by the
state of proteolytic processing at this site.
Because the CB-1 region in Fbn 1 and 2 binds to cells in a
heparin-dependent manner (Ritty et al., 2003), we evaluated
whether heparin can modulate the gastrulation arrest activity of
the CB-1 peptide. Preincubating the CB-1 peptide with 200 μg/
ml heparin before injection into the blastocoel markedly reduces
the gastrulation arrest activity of CB-1, whereas similar
injections of heparin without peptide do not affect gastrulation
(Fig. 5D).
Cell behavior in presence of CB1 peptide
Expressing an amino-truncated form of XF containing the
CB-1 region in DIMZ tissue at gastrulation perturbs the normal
progression of cell behaviors thought to drive convergent
extension in DIMZ tissue (Fig. 3B). To determine if the CB-1
cell-binding region is responsible for this effect on cell motility
we challenged mature notochordal cells visualized in explants
Fig. 4. Effect of CB-1 peptide on development. (A) CB-1-injected embryos exhibit marked axis shortening and open blastopores. (B) Sibling embryos to those in panel
A injected with scrambled peptide develop normally. Scale bars in panels A and B are 1 mm. (C–F) Embryos injected with 300 ng CB-1 peptide exhibiting graded
levels of gastrulation arrest that correlates with fibrillin antibody staining. Scale bars for panels C–F is 0.5 mm. (C) An injected embryo exhibiting strong gastrulation
arrest exhibits little fibrillin staining and a large open blastopore and will develop into an embryo such as shown in panel A. (D) An embryo that is progressively better
at closing its blastopore exhibits progressively more fibrillin staining. The majority of injected embryos appear like those in panel C or D. (E) Embryos that do close
their blastopore can exhibit fibrillin staining defects, such as the somitic staining on only one side seen in dorsal view here (side lacking fibrillin staining indicated by
arrow). (F) A few injected embryos exhibit normal fibrillin staining but still exhibit a slightly abnormal morphology. (G) Time-lapse sequence showing failure of
blastopore closure in an injected embryo; compare to Fig. 1H for normal closure. Scale bar is 0.5 mm. AF=axial fibrillin staining; YP=yolk plug.
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the behavior of notochordal cells is not grossly affected by acute
addition of the CB-1 peptide. When notochordal cells in axial
explants at early neurula stages are challenged with the CB-1
peptide at 50 μg/ml their morphology does not change,
exhibiting a length/width ratio of 2.5 at the beginning of the
experiment and 2.4 at the end, consistent with normal
notochordal cell behavior at neurula stages (Fig. 3C). The
lack of a direct negative effect on the expression of notochordalcell behavior contrasts with the acute gastrulation arrest
phenotype expressed by mid-gastrula embryos injected in the
blastocoel with an equivalent dose of the same CB-1 peptide
(Fig. 5A). We cannot rule out that peptide access to the explant
is less robust than peptide access in the embryo experiments and
therefore leads to a lack of an observed peptide phenotype in
explants, but view this as unlikely because the explants are
made by removing both the ectodermal and endodermal
epithelia leaving just the deep neural layer opposed to the
Fig. 5. Functionally defining the CB-1 domain responsible of perturbing gastrulation. (A) Percent of gastrulation arrested embryos is plotted with SEM from at least
three experiments for uninjected embryos (n=273), or injected with CB-1 peptide (n=205), scrambled peptide (n=272), deletion CB1 peptide (n=84), CB1M1S
(n=68), CB1M2S (n=76), CB1M4S (n=58), CB1M6S (n=74). CB1M6W (n=72), CB1+10 (n=139), CB1M10 (n=50). (B) Table of sequences of injected peptides.
Mutations from CB-1 sequences are shown in bold. (C) Injection of an mRNA encoding a deletion mutant of the TXF-P construct that lacks a functional CB-1 domain
does not perturb gastrulation. Domain structure key is as in Fig. 1. Injection of TXF-P on the dorsal (n=40) but not ventral (n=43) side of the embryo causes
gastrulation arrest. In contrast, expressing an eight amino acid deletion variant, TXF-delCB1, does not cause gastrulation arrest when injected dorsally (n=42) or
ventrally (n=34). (D) The gastrulation arrest phenotype of the CB1 peptide is heparin sensitive. Failure of blastopore closure is plotted for uninjected embryos (n=75),
embryos injected with 30 nl of 200 μg/ml heparin (n=66), injected with 30 nl of 10 mg/ml CB-1 (300 ng) peptide (n=80) or injected with CB-1 peptide (300 ng)
preincubated with 200 μg/ml heparin (n=81).
411P. Skoglund, R. Keller / Developmental Biology 301 (2007) 404–416mesenchymal mesodermal layer. These experiments suggest
that the action of the CB-1 peptide that causes gastrulation arrest
is distinct from the maintenance of notochordal cell behaviors.
Role of the CB-1 region in amino-terminal fragments of XF
Amino-terminal XF fragments exhibit two distinct activities
in the developing embryo; a dominant-negative effect on
microfibril localization to the notochord–somite boundary and
an inhibitory effect on the progression of expression of cell
motile behaviors in DIMZ tissue. Because injecting CB-1
peptide also interferes with microfibril organization, we wanted
to understand the role of the CB-1 domain in the activity
exhibited by amino-terminal XF fragments. To examine this
issue, we assayed the effect on developing embryos of an
expressing variant of TdXF-P lacking the eight amino acids
shown to be required for CB-1 activity as a peptide (Fig. 5A) to
reveal any second mode of action of these amino-terminalfragments that was independent of CB-1 region activity. We
find that TXFdelCB1 does not exhibit gastrulation arrest
activity above background when injected into the dorsal side
of developing embryos (Fig. 5C).
Inhibiting XF translation leads to gastrulation arrest
Both ectopic expression of a dominant-negative form of
XF and injection of the CB-1 peptide block assembly of XF
fibrils and disrupt gastrulation, and both treatments also are
expected to increase the concentration of either monomeric
XF or small, soluble aggregations of XF concomitant with
fibril disruption. To determine the effect of reducing XF
protein levels and thus inhibiting fibril formation without
generating soluble fibrillin we used a morpholino comple-
mentary to XF coding sequences to inhibit translation of the
XF protein in the developing frog. Injection of this XF
morpholino, but not a control morpholino, both reduces the
412 P. Skoglund, R. Keller / Developmental Biology 301 (2007) 404–416amount of XF protein made by the embryo (Fig. 6B) and
perturbs the normal progression of gastrulation leading to a
open blastopore phenotype similar to those seen with
deltaXF/TdXF expression or CB-1 injection (Figs. 6A, C–E).
Because perturbing XF fibril assembly by expressing an
amino-terminal deletion of XF on one side of a DMZ explant
undergoing morphogenesis leads to bent or bifurcated explants,
we assayed the effect of reducing XF translation on only one
side of the embryo. At tailbud stage, 88% of such injected
embryos bend toward the injected side and none bent away (64/
73 embryos), different than either the 12% of control
morpholino-injected embryos that bend (7/60 embryos; 5
towards and 2 away), or the 7% of uninjected embryos thatFig. 6. XF morpholino perturbs gastrulation. Reducing XF translation in embryos bl
embryos is plotted with SEM for XF morpholino (n=93), control MO (n=88) or unin
results in a partial knockdown of XF protein levels, when normalized against a lo
morpholino develop normally. (D and E) Embryos injected with 10 μM XF MO exh
control morpholino do not bend. (G) Embryos injected with 10 μM XF morpholinoexhibit a bend of 30° (5/74 embryos bent in either direction)
(Fig. 6F/G).
Discussion
Xenopus fibrillin (XF) is an ECM molecule that functions in
convergent extension of dorsal, axial and paraxial mesoderm
We use three distinct methods to reveal a role for XF at
gastrulation. We show that expression of amino-terminal
deletions of XF in developing Xenopus embryo (deltaXF/
TdXF), as well as injection of a peptide (CB-1) corresponding
to a putative cell binding domain in XF into embryos, blocksocks the normal progression of gastrulation. (A) Percent of gastrulation arrested
jected embryos (n=94). (B) Western blot for XF reveals XF morpholino injection
ading control (LC). (C) Embryos injected with 10 μM 5-misprime XF control
ibit open blastopores. (F) Embryos unilaterally injected with 10 μM 5-misprime
bend towards the injected side. H=head; YP=yolk plug.
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fibrils in the embryo. In addition, morpholino-mediated
reduction of XF protein in the embryo causes a similar
gastrulation phenotype. Because all three methods of perturbing
XF lead to a similar embryonic phenotype in which morpho-
genesis at gastrulation is compromised, native XF protein
function is required at gastrulation for normal development to
occur.
Several observations argue that native XF functions in
convergent extension of the dorsal mesoderm. Both XF RNA
and protein are expressed at the right time, the midgastrula
stage, and the right place, in the dorsal mesoderm that
undergoes convergent extension or dorsal involuting marginal
zone (DIMZ) (Skoglund et al., 2006). Expression of amino-
terminal XF truncations blocks normal progression of gastru-
lation, and these effects are both temporally specific, occurring
at the onset of native XF expression, and spatially specific,
occurring when deltaXF/TdXF is expressed in dorsal but not
ventral mesoderm. Similarly, injection of the CB-1 peptide into
the blastocoel of developing embryos during convergent
extension blocks normal gastrulation, with the level of matrix
disruption correlating with severity of gastrulation phenotype.
The CB-1 injection phenotype is also temporally specific,
perturbing normal gastrulation within 30 min of injection into
the blastocoel of embryos actively internalizing mesoderm, but
when CB-1 is injected at earlier developmental stages no
phenotype is seen until the onset of mesodermal involution at
mid-gastrulation, concomitant with native XF expression.
The most direct evidence that XF is involved in mesodermal
convergent extension is that Keller sandwiches expressing
deltaXF exhibit dose-dependent curling, that open face explants
unilaterally expressing deltaXF bend towards the injected side,
and that reducing XF translation on one side of intact embryos
also causes bending toward the injected side. In explants,
extension is less vigorous in regions expressing deltaXF,
compromising directed extension and providing a mechanical
mechanism to explain failure of gastrulation in whole embryos
because axially directed convergent extension of the DIMZ
drives normal blastopore closure and embryo elongation (Keller
et al., 2000). Direct, high-resolution analysis of cell motility of
both control and deltaXF-expressing cells in these explants, co-
labeled with GFP, show that the cell behaviors that drive
convergent extension are inhibited by deltaXF, providing a
cellular mechanism for the failure of convergent extension and
the resulting arrest of gastrulation.
In whole embryos, the gastrulation phenotypes due to
deltaXF/TdXF expression, CB-1 injection or morpholino
injection are consistent with failure of convergent extension,
rather than other processes in gastrulation. Convergent
extension of the dorsal mesoderm is required for normal,
asymmetric blastopore closure, DIMZ involution and archen-
teron formation in intact embryos. It is these processes that fail
in experimental embryos. Anterior to posterior progression of
convergent extension of the notochordal and somitic mesoderm
generates arcs of tension that bring about asymmetric involution
and extension of the DIMZ, such that an elongated archenteron
roof with overlying central notochord and bilateral somiticmesoderm is formed (Shih and Keller, 1992b). Local bilateral
disruption of the arcs of convergent tissue in the DIMZ result in
failure of involution and the open blastopore phenotype
(Schectman, 1942), similar to those produced here with
deltaXF/TdXF, CB-1 or morpholino injection. A similar
gastrulation arrest phenotype can be generated by expressing
a dominant-negative cadherin in the DIMZ (Lee and Gumbiner,
1995) and the zebrafish E-cadherin mutant half-baked exhibits a
partially penetrant phenotype of bifucated notochords (Kane et
al., 1996) suggesting that, as one might expect, multiple cellular
and molecular functions are involved in the cellular rearrange-
ments that mediate morphogenesis.
The alternative hypothesis, that deltaXF/TdXF expression,
CB-1 peptide or mopholino injection affect processes other than
convergent extension, such as bottle cell formation, migration
of head mesoderm on the blastocoele roof, convergent
extension of the neural tissue or epiboly of the blastocoel roof
itself, is not supported by our evidence. In the absence of any of
these processes, singly or in combination, gastrulation proceeds
without producing the phenotype we observe in these embryos;
instead blocking these processes result in normal asymmetric
blastopore closure and involution and axial elongation (Keller
and Jansa, 1992; Hardin and Keller, 1988; Keller et al., 2000).
Mechanisms underlying gastrulation arrest
Because both deltaXF/TdXF expression and CB-1 injection
inhibit XF fibril formation and perturb gastrulation, similar to
reducing XF protein levels in the embryo, the normal
localization of near–normal levels of XF to the notochord–
somite boundary is implicated as essential for successful
gastrulation. Because this boundary plays a key role in
convergent extension, disrupting XF protein localization in
this region could affect convergent extension in several ways
(Fig. 7A). First, the boundary has a short range, contact-
mediated effect of inducing the monopolar cell behavior and the
resulting “boundary capture” of the bipolar, mediolaterally
intercalating cells (Shih and Keller, 1992b). Second, the bipolar
MIB that drives convergent extension (Shih and Keller, 1992b)
appears to be induced by signals emanating from the
notochord–somite boundary (Domingo and Keller, 1995). A
defective boundary could affect the cell motility underlying
convergent extension, directly and locally in the first case, and
indirectly in the second case. Third, the XF-containing
boundary matrix could have a direct mechanical effect on
convergent extension by contributing to the observed stiffening
of the DIMZ along the anterior–posterior axis shown by
compression, stress relaxation tests (Moore et al., 1995).
Finally, this matrix may need to be intact to act as a mechanical
integrator for morphogenesis of the DIMZ, incorporating all
cells medial to the boundary into a single, unfractured and
unbent, mature notochord.
Our results are consistent with a defect in one or more of
these boundary functions due to failure of fibrillin fibril
assembly at the notochord–somite boundary. Because directed
extension is perturbed in deltaXF-injected explants, a mechan-
ical role for XF fibrils at the notochord–somite boundary is
Fig. 7. Model for function of Xenopus fibrillin in convergence and extension,
and consequences for morphogenesis of perturbing XF globally and unilaterally.
All panels show an open face DIMZ explant before and after autonomous
extension. For each, extension is downward (posterior) with yellow representing
notochord and red lines indicating the location of the presumptive notochordal–
somitic boundary (upper panels), or the localization of XF in the mature, matrix-
rich notochordal–somitic boundary (lower panels). (A) In normal open face
DIMZ explants cells (open circles) are induced to become bilaterally protrusive
and elongate (exhibit MIB), bind to the XF containing notochord–somite
boundary, where they exhibit local inhibition of protrusion. These cells then
converge towards the midline, dragging the boundary with them and causing
directed extension of the notochord (shown in the extended explant). In this
model XF at the boundary functions in the process of directing extension
posteriorly and may function in regulating cell motility at the boundary. (B) In
explants in which XF deposition at the boundary is globally perturbed, either by
expressing deltaXF widely or injecting the CB-1 peptide, fibrillin fibril
localization to both of the bilateral boundaries is disrupted. This leads to twisted
notochords as extension is no longer globally directed in the posterior direction,
and in whole embryo experiments leads to failure of blastopore closure. (C) In
explants in which XF is compromised unilaterally bending occurs, again
suggesting that XF fibrils normally function to direct extension posteriorly.
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would also fully explain the gastrulation arrest phenotypes
generated with deltaXF/TdXF, CB-1 peptide or morpholino
injection. In this model, XF fibrils serve as a substrate for MIB-
expressing cells, mechanically integrating the force generated
by cell motility in the notochord into directed, posterior,
extension while stiffening the axis. This model predicts that
disrupting or reducing XF fibrils in the embryo will alter the
biomechanical properties of the developing axis.
Our results also show that MIB is dramatically reduced
specifically in deltaXF-expressing regions, suggesting that
misregulated XF fibril formation is capable of directly or
indirectly regulating cell motility in the axis. Perturbing the
patterned expression of cell motility could also cause
gastrulation arrest in whole embryos. However, because we
do not see a direct inhibitory effect on MIB due to the CB-1
peptide, a failure of a mechanical role for XF fibrils is likely the
primary defect in CB-1-injected embryos, whereas in deltaXF/
TdXF-injected embryos we have evidence that disruption of
both a mechanical role for fibrils in the boundary as well as
misregulation of local cell motility combine to produce thegastrulation arrest phenotype. In combination, these data
suggest that the native XF fibrils serve at least two functions
at gastrulation, acting both to mechanically integrate local cell
motility in order to translate it into tissue level directed
extension, as well as to regulate this local cell motility.
Role for the CB-1 domain
Both deltaXF/TdXF expression and CB-1 peptide injection
affect convergent extension; because deletion of the CB-1
domain from TdXF removes this activity, this domain appears
to be central to the gastrulation phenotype in both cases. The
observation that the 17-mer CB-1 homology domain from
human Fbn 1 supports cell attachment to a wide variety of cells
indicates the presence of a widely expressed but as yet
unidentified receptor (Ritty et al., 2003). Because this cell
attachment can be competed with heparin and can be blocked by
pretreating cells with heparitinase II, this receptor is likely a cell
surface heparan sulfate proteoglycan. In cell culture, Fbn 1 and
2 fibril assembly can be blocked with soluble heparin, and these
molecules each have several distinct heparin binding sites,
including the CB-1 homology domain (Tiedemann et al., 2001;
Ritty et al., 2003). Assembly requires specific cell types,
suggesting a role for an unidentified receptor (Dzamba et al.,
2001) and generates fibrillin molecules arrayed in a head-to-tail
fashion in microfibrils suggesting the presence of at least two
multimerization domains per molecule (Reinhardt et al., 2000).
We propose that the CB-1 domain on XF mediates heparin-
dependent binding to a site on cell surfaces, that this is an
obligate step in the process of fibril assembly and that the
mechanism of action of the CB-1 peptide is to block this
interaction and thus fibril assembly. This view is strongly
supported by our observation that pretreating CB-1 peptide with
heparin reduces its gastrulation arrest activity.
A human MFS Fbn 1 allele with a point mutation in the CB-1
homology domain (R2726W, analogous to the mutant CB-1
peptide CB1-R6W in this study) supports the notion that the
CB-1 domain is critical for Fbn assembly (Milewicz et al., 1995;
Raghunath et al., 1999). This family presents an extremely mild
form of MFS and may represent the null phenotype. Dermal
fibroblasts cultured from one of these patients produce and
secrete normal amounts of Fib-1 protein but exhibit half of
normal Fib-1 deposition into matrix, implicating a functional
CB-1 homology domain in fibril assembly. Because this
mutation is in the consensus furin-processing site at the Fbn 1
carboxy-terminal and inhibits proteolytic processing, this has
been interpreted as evidence that carboxy-terminal processing is
required for assembly into the matrix. However, this does not
explain why this allele does not exhibit a dominant-negative
activity leading to more severe MFS because premature
termination Fbn 1 alleles exhibit dominant-negative effects on
fibrillin assembly into matrix (Schrijver et al., 2002). We
suggest that in addition to a processing defect this R2726W
mutant also fails to interact with a cell surface receptor through
its CB-1 domain, and this is the reason this allele both does not
assemble into matrix and does not exhibit dominant-negative
activity.
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deletions
Amino-terminal XF truncations that contain the CB-1 domain
also perturb gastrulation, and this domain may be functioning to
block fibril assembly in a manner analogous to what we envision
for CB-1 peptide injection. This view is strongly supported by
the observation that expressing TdXF-del8 in embryos, in which
the CB-1 domain is inactivated, does not cause gastrulation
arrest. However, deltaXF/TdXF expression also perturbs the
normal progression of cell behaviors in the dorsal axis, and this
phenotype is not recapitulated by soluble CB-1 peptide. We
suggest that this phenotype is due to the production of “mini-
fibrils”, consisting of native, full-length fibrillin associated with
the amino-terminal truncated deltaXF/TdXF protein product,
which are not created when the CB-1 peptide in injected. We
hypothesize that these minifibrils are responsible for the
inhibition of expression of MIB in injected regions that we
observe in deltaXF-injected regions. Because fibrillins exhibit
integrin binding activity (Robinson and Godfrey, 2000) through
domains that are absent in the deltaXF/TdXF constructs, integrin
binding activity of native fibrillin molecules assembled into
minifibrils may mediate this effect. One normal function of the
notochord–somite boundary is to induce local inhibition of
protrusive activity (Shih and Keller, 1992b); we suggest that
fibrillin normally mediates this inhibition at the boundary and
that minifibrils also exhibit this activity but are mislocalized
away from the boundary, leading to the observed inhibition of
MIB cell motility in deltaXF/TdXF-expressing regions.
Multiple roles for fibrillin at gastrulation
At gastrulation, XF is expressed specifically in DIMZ tissue
undergoing morphogenesis and is localized to the presumptive
notochordal–somitic boundaries as microfibrils. The transfor-
mation of the short but wide presumptive notochordal region
into a one cell wide, elongated notochord occurs by progressive
anterior to posterior and lateral to medial expression of both
mono- and bi-polar cell intercalation behavior, which results in
pulling the boundaries medially, “zipping up” of the notochord
field and extension in the posterior direction (Fig. 7A). Here we
present evidence that XF fibrils in the notochord–somite
boundary serve as mechanical integrators of this cell behavior
in dorsal, axial tissue, required for directed extension of dorsal
mesoderm. In this model, the XF matrix imparts a mechanical
stability to the extending boundary, and deltaXF/TdXF
expression, CB-1 application or reduction of XF levels may
generate a mechanically weak matrix, prone to fracture when
subjected to use as a substrate for cell spreading or as a
mechanical integrator during notochord formation. This results
in the bent and multiple notochord phenotypes (Figs. 7B, C). A
second role for XF consistent with this work is as a signal to
notochordal cells that they are at the notochord–somite
boundary, leading these cells to locally cease protrusive activity
and transit from bipolar to monopolar protrusiveness. We
postulate that interaction with truncated XF spatially misregu-
lates this activity of native XF, this hypothesis remains to betested. Microfibrils are also capable of modulating signal
transduction (Arteaga-Solis et al., 2001; Charbonneau et al.,
2003); but because dorsal cell fates are not perturbed in these
experiments no such role in mesodermal induction was
uncovered here. In combination, three distinct interdictions
reveal XF fibrils are required for gastrulation and suggest that
this requirement operates at several levels including (1) as an
ECM substrate for notochordal cells responsible for mechan-
ically integrating local cell motility into tissue-level directed
force, (2) as a stiffening element in the developing axis and (3)
as a signaling center, regulating cell motility in and around the
notochordal–somite boundary.
Materials and methods
Embryos, manipulations, immunochemistry and Western blot
Both pigmented and albino Xenopus embryos were generated by
conventional techniques, and sandwich and open-face DIMZ explants were
made from stage 10 embryos and cultured as described (Skoglund et al., 2006).
Dorsal, axial explants were made from St. 14 embryos by removing the
superficial endodermal epithelium to reveal the notochord. Transplantation
studies involved making DIMZ explants from injected animals and transplanting
a small number of both control and experimentally injected notochordal cells
into a naive host and re-explanting into culture, and this host explant converges
and extends (see Fig. 3A). Both groups of transplanted cells express GFP so
these cells can be followed in the context of the morphogenesis of the host
explant, and MIB is assayed by cell morphology whereas mediolateral
intercalation of transplanted cells is inferred by the relative breakup of the
transplanted group of cells in the context of the morphogenesis of the host
explant (Fig. 3B, control cells on right side of arrowheads, experimental cells on
left side). Other expressing cells from these explants were plated on dots created
by allowing 10 μl of 100 μg/ml fibronectin to dry on a culture dish. Fibrillin and
notochord were detected with the monoclonal antibodies JB3 (Rongish et al.,
1998) and Tor7, respectively, by standard techniques (Skoglund et al., 2006).
Western blotting was performed and quantitated as described using the JB3
antibody to detect XF, and a cross-reacting band running at 200 kDa is used as a
loading control (Skoglund et al., 2006).
Production of constructs and RNA preparations and microinjections
Capped mRNAwas prepared utilizing the Maxiscript kit (Ambion). DeltaXF
(linearized with EcoRI and transcribed with SP6) was constructed by subcloning
a 4.4-kb BamHI–EcoRI fragment from pXND4 (Skoglund et al., 2006) into
BamHI–EcoRI cut N-CadΔE (Kintner, 1992), resulting in an in frame fusion of
30 amino acids of N-cadherin signal sequence ahead of carboxy-terminal XF
coding sequences. TdelXF (EcoRI/SP6) was constructed by replacing a
BamHI–ApaI fragment with a PCR product generated with (ATAGGATC-
CGGGGAGCAAAAGCTTATTTCTGAGGAGGATCTGCATCATCATCAT-
CATCAT/gacacagatgtagc), removing 17 amino acids encoding a partial EGF
repeat including potentially unpaired cysteine residues present in deltaXF.
Carboxy terminal deletions of TdelXF were constructed by removing a BstII–
NsiI fragment and replacing it with PCR products generated with (TCTTGC-
ATTGATAACAATG/catatatgcatcatcctgagacacagtgcccttg) to generate TdelXF-R
and (TCTTGCATTGATAACAATG/atgatatcatcatcctcgcttggggtacccatt) for
TdelXF-P, whereas TXF-delCB1 was constructed by replacing a KpnI–EcoRI
fragment with a PCR product generated with (TCAATGGGTACTAGCCCAA-
GAAAGGAAGGCAGAGGCGAAATGCAGATGAC/gtaatacgactcactataggg).
RNA encoding bovine pre-prolactin was from pSP35T (SP6/EcoRI), Green
Fluorescent Protein was from pRN3GFP (T3/SFI1), or the S65T mutant pcs2t/
S65T (SP6/Not1), and the membrane-localized form of GFP was from GAP-43-
GFP (SP6/NotI). Embryos were injected with 5–20 nl of 50–200 ng/μl RNA in
water in 1 or 2 blastomeres at the 2- or 4-cell stage, and dorsal or ventral
marginal zone targeting was accomplished by using pigment cues (Lee and
Gumbiner, 1995).
416 P. Skoglund, R. Keller / Developmental Biology 301 (2007) 404–416Immunochemistry, peptides and morpholinos
Custom synthetic peptides (Synpep or Invitrogen) were resuspended at
10 mg/ml in water. Injection was of 300 ng peptide/embryo into the blastocoele
of developing embryos at stage 11 for all 17-mer peptides, and 450 ng peptide/
embryo for all 27-mer peptides to maintain similar molarities. A morpholino
complementary to XF was produced (gcctatgttatatgaacagcagca) (Genetools,
Inc.) as well as a control morpholino (gcgtatcttatatcaagagcagga) that varies at
five nucleotides. Injection was of 5 nl of 1 mM morpholino in one or both
blastomeres at 2 cell stage to achieve 10 μM morpholino in the embryo.
Injection protocol was as above, and embryos were cultured in 2/3 MBS at room
temperature. Unilateral injections included 50 ng ruby-labeled dextran
(Molecular Probes D-1817) as a tracer. Embryos were dissected out of their
vitelline membranes, cultured at least two hours to allow them to straighten and
then scored as bent if they exhibit a persistent axial bend of at least 30° using
fluorescence to determine if bend is toward or away from the injected side.
Time-lapse video
Low-light fluorescence video microscopy was done with either a Nikon
Diaphot or a Nikon IX70 inverted microscope, using high numerical aperture
10, 20 and 60× fluorescence objectives. Imaging was done with a Hammatsu
SIT camera, model 2400-08, or model C4742-95. Image processing was
accomplished using Image1 or Metamorph software (both Universal Imaging)
and images were post-processed using ImageJ (NIH) or Photoshop (Adobe).
Confocal imaging was performed with a Nikon IX70 with a BioRad laser head
and software at the Keck Center for Cellular Imaging at UVA. Framing intervals
of 30 s to 3 min were used and image processing consisted of frame averaging
and brightness and contrast adjustment as described previously (Shih and Keller,
1992a).
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